We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Biomarker Could Help Pinpoint Which Cancers Are Sensitive to Diabetes Drug

News   May 20, 2020 | Original story from Van Andel Institute (VAI)

 
Biomarker Could Help Pinpoint Which Cancers Are Sensitive to Diabetes Drug
 
 
Advertisement
 

RELATED ARTICLES

A Step Closer to A Blood Test for Diagnosing Mood Disorders?

News

A new study published in Molecular Psychiatry outlines the development of an RNA biomarker-based blood test for distinguishing how severe an individual's depression is, determining the risk of a patient developing severe depression in the future, determining the risk of future bipolar disorder and tailored medication choices for patients.

READ MORE

Repurposing Drugs To Manage COVID-19 Progression

News

Researchers have used a large-scale human genetics study to identify drug targets important for managing COVID-19 in its early stages.

READ MORE

Tacking Treatment-Resistant Fungus With New Formulation of Existing Drugs

News

Researchers have discovered a formulation of existing medicines that can significantly reduce the presence of the fungus Candida auris on skin, controlling its spread and potentially keeping it from forming infections that have a high mortality rate.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery Genomics Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE